Cactus Life Sciences Top 5 Trends of 2024

Cactus Life Sciences’ Top 5 Trends of 2024: Insights Driving Tomorrow’s MedComms

Here, we revisit our most thought-provoking articles and whitepapers, each addressing pivotal trends that influence the ever-evolving biopharma landscape...
Read More

Top Stories

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Involve Medical Affairs in insight management, early phases of clinical trials, etc.

It’s Never Too Soon: How and When to

Engagement with Medical Affairs is critical at every...
Leverage Social Media to Transform Medical Affairs | Promoting Disease Awareness, Ensuring Compliance and Assessing Outcomes

Leveraging Social Media to Transform Medical

This whitepaper explores the role of social media in...
people-forming-a-chain

Why Is It Important to Include Patients as Peer Reviewers

Patient peer reviews offer an amazing opportunity to see how HCPs and pharmaceutical companies are...
man-accessing-data

New Open Data Sharing Policies: WHO and NIH Take Big Steps to Improve Public Health

Making research and data reproducible is vital to improving public health and reinstating trust in...
a-man-questioning-medical-device-regulatory-options

Which Regulatory Requirements Are Applicable to “Legacy” Devices?

Understanding the requirements for your medical device is vital in today’s market. But are these...
Health Literacy

Health Literacy – Cactus Life Sciences Leads the Way

It’s our responsibility as an industry to emphasize the importance of health literacy and help...
broken-communication

Navigating the Two-Way Street: 3 Ways to Avoid Dead Ends in HCP-Patient Conversations

Today's patients have access to a multitude of resources about their health and condition. HCPs...
EU MDR,Compliance,Rules,MedTech,Law,Regulation,Policy,Documents,Medical Device

Ensuring Alignment Across EU MDR Deliverables

How to avoid all these pitfalls and keep thriving in the EU Medical Devices market?...

Learn more ABOUT our company.